Packing of Perianal Abscess Cavities

Not Applicable

Completed

• Conditions: Perianal Infections; Abscess; Anus; Peri Rectal Abscess; Abscess Anorectal; Perianal Abscess

• Registration Number: NCT03315169
• Lead Sponsor: Manchester University NHS Foundation Trust

Brief Summary

The aim of this trial is to compare internal wound packing to no packing in postoperative management following incision and drainage of perianal abscess. Participants will be randomised 1:1 to either the packing or non-packing arm.

Detailed Description

Perianal abscess is common, affecting 18,000 patients annually in England. Management has remained largely unchanged for over 50 years, and comprises surgical incision and drainage followed by continued internal wound dressing (packing) until healed. Packing is thought to reduce the rate of recurrent abscess and perianal fistula; a known complication of perianal abscess. Perianal fistula frequently requires multiple operations to resolve. The evidence for postoperative packing is limited¹ and may expose patients to painful procedures with no clinical benefit, and at considerable increased cost².

A multi-centre observational study of outcomes after drainage of perianal abscess (PPAC²) (n=141) found packing to be painful (2-3 fold increase in Visual Analogue Score pain scores during packing) and costly (estimated cost of £280 per patient; overall cost in the United Kingdom of £5 million annually). Fistula rate was 27%.

This study is a randomised controlled trial designed to assess whether there are differences between non-packing and packing of the perianal abscess cavity in terms of the short term negative effects of packing (pain, quality of life, return to work) whilst assessing the impact on key clinical outcomes (wound healing, fistulae formation) and resource use/cost.

All participants will be required to complete pain diaries following discharge from hospital. Clinical follow up to assess healing and other key clinical outcomes will take place at 4, 8 (if not healed at 4 weeks) and 26 weeks. Further data will be collected from National Health Service Registries at 52 weeks in order to assess abscess recurrences and fistulae formation.

Study Timeline

• Study First Submitted: 2017-10-11
• Study First Submitted QC: 2017-10-16
• Study First Posted: 2017-10-20
• Study Start: 2018-02-14
• Primary Completion: 2020-06-12
• Study Completion: 2020-06-12
• Status Verified: 2020-09
• Last Update Submitted: 2020-09-08
• Last Update Posted: 2020-09-09

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 433

Inclusion Criteria

1. Aged 18 or over
2. Undergoing surgical incision and drainage of a primary perianal abscess

Exclusion Criteria

1. Suspected inflammatory bowel disease
2. Fournier's Gangrene
3. Horseshoe (bilateral) abscess
4. Fistula-in-ano
5. Multiple abscess

Study & Design

• Study Type: INTERVENTIONAL
• Study Design: PARALLEL

Primary Outcome Measures

Name	Time	Method
Wound-related pain intensity	Mean score over first 10 post-operative days	Wound-related pain intensity (worst pain during previous 24 hours) measured using a single 100mm Visual Analogue Scale where 0 represents 'no pain' and 100 represents 'worst pain possible'. The pain Visual Analogue Scale is a continuous scale comprised of a horizontal line 100mm in length, anchored by 2 verbal descriptors, one for each symptom extreme, where 0 represents 'no pain' and 100 represents 'worst pain possible'. The mean score over the first 10 post-operative days will be used.

Secondary Outcome Measures

Name	Time	Method
Clinical diagnosis of perianal abscesses recurrence after healing	52 weeks post-operatively	Clinical diagnosis of perianal abscesses recurrence after healing, ascertained either through clinical follow-up as part of trial procedures or via central National Health Service registries.
Time to return to work or normal function	Up to 52 weeks post-operatively	Length of time, measured in days, between operation and return to work or normal function.
Rate of wound healing	Four and eight weeks post-operatively	Rate of wound healing (complete epithelialization)
Patient satisfaction with wound management	On the 21st post-operative day	Patient satisfaction with wound management measured using a five point Likert scale. Patients are asked to mark the extent to which they agree with the statement 'I am satisfied with the way my wound has been treated following my surgery' where 1 equates to 'strongly disagree' and 5 equates to 'strongly agree'.
Dressing use	Up to 52 weeks post-operatively	Number of dressings used between time of operation up until week 52.
Health related quality of life	On the 21st post-operative day	Health related quality of life measured using EuroQol EQ-5D-5L quality of life questionnaires. The EQ-5D-5L descriptive system comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension now has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement in each of the 5 dimensions. This decision results in a 1-digit number expressing the level selected for that dimension. The digits for 5 dimensions can be combined in a 5-digit number describing the respondent's health state.
Health utility	On the 21st post-operative day	Health utility measured using EuroQol EQ-5D-5L quality of life questionnaires. The EQ-5D-5L descriptive system comprises 5 dimensions: mobility, self-care, usual activities, pain/discomfort and anxiety/depression. Each dimension now has 5 levels: no problems, slight problems, moderate problems, severe problems, and extreme problems. The respondent is asked to indicate his/her health state by ticking (or placing a cross) in the box against the most appropriate statement in each of the 5 dimensions. This decision results in a 1-digit number expressing the level selected for that dimension. The digits for 5 dimensions can be combined in a 5-digit number describing the respondent's health state.
Chronic post-surgical pain	4, 8 and 26 weeks post-operatively	Chronic post-surgical pain measured using the Brief Pain Inventory - Short Form. The Brief Pain Inventory - Short Form assesses the severity of pain and the impact on daily functions. Pain is assessed at its "worst," "least," "average," and "now" (current pain), measured on a scale of 1-10 where 1 represents "no pain" and 10 represents "pain as bad as you can imagine". The four items will be represented singly but a composite of the four pain items (a mean score) will be presented as supplemental information. Pain interference (impact of pain on seven daily activities) will be scored as the mean of the seven interference items. These items are scored between 1 and 10, where 1 represents "does not interfere" and 10 represents "completely interferes".
Hospital admission time	Up to 52 weeks post-operatively	Number and length of hospital admissions as recorded in NHS central registries - Hospital Episodes Statistics.
Dressing-change related pain intensity	First 10 post-operative days	Pain before, during and after dressing change measured using a 100mm Visual Analogue Scale where 0 represents 'no pain' and 100 represents 'worst pain possible'. The pain Visual Analogue Scale is a continuous scale comprised of a horizontal line 100 mm in length, anchored by 2 verbal descriptors, one for each symptom extreme. The mean score for each timepoint (before, during and after) over the first 10 post-operative days will be used.
Health Professional contact time	Up to 52 weeks post-operatively	Number of contacts with a Health Professional regarding perianal abscess or post-surgical complications between time of operation and 52 weeks post-operatively.
Cost	Up to 52 weeks post-operatively	Cost as applied to resource use data (see outcome 9-12)
Assessment of pain control methods	21 days post-operatively	Assessment of pain control methods (i.e. pain control medications) using Patient Global Assessment of the method of pain control where a rating of the pain control method over the past 24 hours is rated as being one of "poor," "fair," "good," or "excellent".
Fistula rate	Up ro 52 weeks post-operatively	Fistula rate observed during clinical follow up and through Hospital Episodes Statistics

Trial Locations

Locations (50)

Salford Royal Hospital; 🇬🇧 Salford, Greater Manchester, United Kingdom

West Middlesex University Hospital (Isleworth); 🇬🇧 Isleworth, Middlesex, United Kingdom

John Radcliffe Hospital; 🇬🇧 Oxford, Oxfordshire, United Kingdom

Mew Cross Hospital; 🇬🇧 Wolverhampton, West Midlands, United Kingdom

Huddersfield Royal Infirmary; 🇬🇧 Huddersfield, West Yorkshire, United Kingdom

Pindersfields General Hospital; 🇬🇧 Wakefield, West Yorkshire, United Kingdom

Salisbury District Hospital; 🇬🇧 Salisbury, Wiltshire, United Kingdom

Aberdeen Royal Infirmary; 🇬🇧 Aberdeen, United Kingdom

Bangor Hospital, Betsi Cadwaladr University Health Board; 🇬🇧 Bangor, United Kingdom

Furness General Hospital; 🇬🇧 Barrow In Furness, United Kingdom

Scroll for more (40 remaining)